Synexus Polska Sp. z o.o.

This site is actively involved in respiratory tract diseases and immune system processes, with studies focused on conditions such as asthma, chronic obstructive pulmonary disease, and seasonal allergic rhinitis. The trials are designed to assess new treatment options and better control of symptoms in people with ongoing airway and allergy-related disease.

• Testing new approaches for uncontrolled asthma and COPD
• Evaluating relief for seasonal allergic rhinitis and rhinoconjunctivitis
• Studying long-term management of breathing and allergy symptoms

Research at the Wroclaw site includes both adult and pediatric allergy studies, reflecting a broad effort to improve daily disease control and quality of life.

A major part of the research portfolio centers on skin and connective tissue diseases and immune system diseases, especially atopic dermatitis, plaque psoriasis, prurigo nodularis, and vitiligo. These trials are mainly aimed at finding more effective ways to reduce inflammation, itching, and visible skin symptoms.

• Investigating treatments for moderate to severe atopic dermatitis
• Studying therapies for psoriasis, prurigo nodularis, and vitiligo
• Assessing long-term safety and symptom control in chronic skin disease

The site contributes to research that helps clarify how new therapies may improve comfort, appearance, and day-to-day functioning for people with persistent inflammatory skin conditions.

Clinical trial activity also covers digestive system diseases and related physiological phenomena, with work in Crohn’s disease, eosinophilic esophagitis, and liver conditions such as NASH and MASH. These studies are intended to evaluate whether new therapies can improve disease control, support tissue healing, and slow progression of chronic gastrointestinal and liver disorders.

• Testing treatments for Crohn’s disease and eosinophilic esophagitis
• Evaluating therapies for NASH and MASH with fibrosis
• Measuring long-term benefit in chronic digestive and liver disease

This area shows a strong focus on conditions that can affect nutrition, comfort, and long-term organ health.

The site runs multiple trials in cardiovascular diseases, nutritional and metabolic diseases, and kidney-related conditions. Main diseases under study include hypertension, hyperlipidemia, obesity, type 2 diabetes mellitus, and chronic kidney disease, with research aimed at reducing future heart and kidney complications.

• Evaluating therapies for high cardiovascular risk and established heart disease
• Studying treatment options for CKD, hypertension, and metabolic imbalance
• Assessing approaches to lower LDL cholesterol and improve cardiometabolic health

These trials reflect a broad effort to improve prevention and long-term outcomes in people at risk of serious vascular and metabolic disease.

Another important research stream includes immune system diseases, musculoskeletal diseases, and musculoskeletal and neural physiological phenomena. Studies are being conducted in psoriatic arthritis, systemic lupus erythematosus, cutaneous lupus erythematosus, osteoporosis, and chronic nerve pain, with the goal of improving symptom control and long-term disease management.

• Testing new therapies for psoriatic arthritis and lupus
• Comparing treatment options for postmenopausal osteoporosis
• Studying relief for chronic neuropathic pain

At Synexus Polska Sp. z o.o., these studies support research into conditions that can affect mobility, daily comfort, and long-term quality of life.

The portfolio includes work in bacterial infections and mycoses and virus diseases, with studies related to respiratory syncytial virus, recurrent herpes labialis, and prevention of invasive extraintestinal pathogenic Escherichia coli disease. These trials aim to improve prevention, strengthen immune protection, and evaluate whether new or combined vaccine strategies can provide better protection.

• Assessing vaccine responses for RSV and influenza
• Studying prevention of ExPEC disease
• Evaluating treatment for recurrent herpes labialis

This area highlights the site’s role in both treatment and prevention research for common and potentially serious infectious diseases.

The site also supports research in nervous system diseases and related cognitive outcomes, including cognitive impairment associated with post-COVID-19 syndrome and chronic pain syndromes affecting the nervous system. These studies are designed to see whether new therapies can improve thinking, memory, and symptom burden after infection or nerve injury.

• Evaluating treatments for post-COVID cognitive impairment
• Studying therapies for chronic peripheral neuropathic pain
• Exploring ways to improve everyday cognitive function and comfort

The research adds an important dimension to the site’s broader clinical program by addressing conditions that can be difficult to diagnose and manage.